1. Home
  2. RYTM vs ARLP Comparison

RYTM vs ARLP Comparison

Compare RYTM & ARLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • ARLP
  • Stock Information
  • Founded
  • RYTM 2008
  • ARLP 1971
  • Country
  • RYTM United States
  • ARLP United States
  • Employees
  • RYTM N/A
  • ARLP N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • ARLP Coal Mining
  • Sector
  • RYTM Health Care
  • ARLP Energy
  • Exchange
  • RYTM Nasdaq
  • ARLP Nasdaq
  • Market Cap
  • RYTM 3.2B
  • ARLP 3.4B
  • IPO Year
  • RYTM 2017
  • ARLP 1999
  • Fundamental
  • Price
  • RYTM $52.70
  • ARLP $26.98
  • Analyst Decision
  • RYTM Strong Buy
  • ARLP Strong Buy
  • Analyst Count
  • RYTM 12
  • ARLP 1
  • Target Price
  • RYTM $68.58
  • ARLP $29.00
  • AVG Volume (30 Days)
  • RYTM 544.5K
  • ARLP 279.9K
  • Earning Date
  • RYTM 05-06-2025
  • ARLP 04-28-2025
  • Dividend Yield
  • RYTM N/A
  • ARLP 10.50%
  • EPS Growth
  • RYTM N/A
  • ARLP N/A
  • EPS
  • RYTM N/A
  • ARLP 2.77
  • Revenue
  • RYTM $130,126,000.00
  • ARLP $2,448,708,000.00
  • Revenue This Year
  • RYTM $47.06
  • ARLP N/A
  • Revenue Next Year
  • RYTM $68.10
  • ARLP $3.83
  • P/E Ratio
  • RYTM N/A
  • ARLP $9.61
  • Revenue Growth
  • RYTM 68.06
  • ARLP N/A
  • 52 Week Low
  • RYTM $35.17
  • ARLP $20.05
  • 52 Week High
  • RYTM $68.58
  • ARLP $30.56
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 48.00
  • ARLP 56.84
  • Support Level
  • RYTM $52.54
  • ARLP $26.00
  • Resistance Level
  • RYTM $55.21
  • ARLP $26.71
  • Average True Range (ATR)
  • RYTM 2.05
  • ARLP 0.57
  • MACD
  • RYTM 0.36
  • ARLP 0.20
  • Stochastic Oscillator
  • RYTM 47.82
  • ARLP 90.24

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About ARLP Alliance Resource Partners L.P. Common Units representing Limited Partners Interests

Alliance Resource Partners LP operates as a coal mining company based in the United States. It has four segments Illinois Basin, Appalachia, Oil & Gas Royalties and Coal Royalties. The Illinois Basin comprises underground mining complexes in Illinois, Indiana, Kentucky, Maryland and West Virginia. The Appalachia segment comprises the Mettiki mining complex, the Tunnel Ridge mining complex and the MC Mining complex. The Oil & Gas Royalties has oil & gas mineral interests held by AR Midland and AllDale I & II and includes Alliance Minerals' equity interests in both AllDale III and Cavalier Minerals. The Coal Royalties has included coal mineral reserves and resources owned or leased by Alliance Resource Properties.

Share on Social Networks: